944457-73-2

Basic information

• Product Name: C₃₃H₃₃N₃O₆
• Synonyms: C₃₃H₃₃N₃O₆
• CAS NO: 944457-73-2
• Molecular Weight: 567.642
• Mol File: 944457-73-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₃₃H₃₃N₃O₆(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₃H₃₃N₃O₆(944457-73-2)
• EPA Substance Registry System: C₃₃H₃₃N₃O₆(944457-73-2)

Safety Data

• Hazardous Substances Data: 944457-73-2(Hazardous Substances Data)

Upstream product

• 2130-96-3 O-benzyl-N-tert-butoxycarbonyl-L-tyrosine 
• 6272-52-2 2-(4-nitrophenyl)aniline 

Downstream Products

• 944457-74-3 [1-(4'-amino-biphenyl-2-ylcarbamoyl)-2-(4-benzyloxyphenyl)ethyl]carbamic acid tert-butyl ester 
• 944457-66-3 octanedioic acid {2'-[2-amino-3-(4-benzyloxyphenyl)propionylamino]biphenyl-4-yl}amide benzyloxyamide 
• 944457-75-4 [1-[4'-(7-benzyloxycarbamoyl-heptanoylamino)biphenyl-2-ylcarbamoyl]-2-(4-benzyloxy-phenyl)ethyl]carbamic acid tert-butyl ester 

Relevant articles and documents

ISOFORM-SELECTIVE HDAC INHIBITORS

One aspect of the invention relates to isoform-selective HDAC inhibitors. Also provided are methods of sensitizing a cancer cell to the cytotoxic effects of radiotherapy. The invention also provides methods for treating cancer, methods for treating neurological diseases and methods for treating malaria. Additionally, the invention provides pharmaceutical compositions comprising an HDAC inhibitor of the invention; and kits comprising a an HDAC inhibitor of the invention.